Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Stem Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02759822
What this trial is testing

Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias

Who this might be right for
Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Leonardo Javier Arcuri 30
Not applicableLooking for participantsNCT05198570
What this trial is testing

Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients

Who this might be right for
Herpesviridae InfectionsHerpes Simplex 1Varicella Zoster Virus Infection+2 more
University of Pisa 200
Not applicableStudy completedNCT01362179
What this trial is testing

National Marrow Donor Program Long-Term Donor Follow-Up

Who this might be right for
Hematologic Neoplasms
Center for International Blood and Marrow Transplant Research 21,974
Early research (Phase 1)Ended earlyNCT04679194
What this trial is testing

Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT

Who this might be right for
AML/MDS
Mana Therapeutics 11
Testing effectiveness (Phase 2)Ended earlyNCT05626322
What this trial is testing

Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Pfizer 6
Large-scale testing (Phase 3)Study completedNCT01296503
What this trial is testing

Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Grupo de Estudos Multicentricos em Onco-Hematologia 213
Large-scale testing (Phase 3)UnknownNCT00003680
What this trial is testing

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
Scottish Cancer Therapy Network 300
Testing effectiveness (Phase 2)Study completedNCT00004061
What this trial is testing

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

Who this might be right for
LeukemiaLymphomaOral Complications
Memorial Sloan Kettering Cancer Center 111
Testing effectiveness (Phase 2)Study completedNCT01018979
What this trial is testing

Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaHodgkin Disease
GPCR Therapeutics, Inc. 19
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)WithdrawnNCT02503280
What this trial is testing

The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.

Who this might be right for
Chronic Ischemic Left Ventricular DysfunctionMyocardial Infarction
Joshua M Hare
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07290946
What this trial is testing

Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors

Who this might be right for
Xerostomia Due to Hyposecretion of Salivary GlandXerostomia Due to RadiotherapySjögren´s Syndrome
Christian von Buchwald 100
Testing effectiveness (Phase 2)Study completedNCT01745588
What this trial is testing

Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 23
Not applicableUnknownNCT06506396
What this trial is testing

Rehabilitation Needs for Hematologic Cancer Candidate for Hematopoietic Stem Cell Transplantation or CAR T-Cell Therapy

Who this might be right for
Stem Cell TransplantationImmunotherapyCAR T-Cell Therapy
University of Modena and Reggio Emilia 20
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Testing effectiveness (Phase 2)Study completedNCT01814488
What this trial is testing

A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia

Who this might be right for
Acute Leukemia
Gruppo Italiano Trapianto di Midollo Osseo 101
Testing effectiveness (Phase 2)Ended earlyNCT01453088
What this trial is testing

Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 63
Testing effectiveness (Phase 2)UnknownNCT03570983
What this trial is testing

A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion

Who this might be right for
Multiple Myeloma
Swedish Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT06075927
What this trial is testing

Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT

Who this might be right for
CMV InfectionEBV InfectionStem Cell Transplant
Peking University People's Hospital 29
Next Page